Every finding on record at Mercury Hospice, Inc.

Upon patient record review, 1 of 14 (Patient #10) did not have evidence in the patient record that a review was completed of all prescription and non-prescription medications, including herbal remedies that could affect drug therapy. This review includes, but is not limited to: • Effectiveness of drug therapy • Drug side effects • Actual or potential drug interactions • Duplicate drug therapy • Drug therapy currently associated with laboratory monitoring Pt 10: Voltaren 1% topical gel ordered 3/1/24 twice daily to affected area. Diclofenac Sodium 1% topical gel previously ordered 2/25/24, apply twice daily to affected area. Voltaren is the brand name of the generic Diclofenac Sodium. No evidence of either medication being discontinued correcting duplicate drug therapy.

Upon client record review, 4 of 14 (Patient #1, 2, 3, & 8) did not have evidence that the IDG ensures that the care and services are provided in accordance with the plan of care. Patient 1: MSW visit 4/9/24 conducted via telephone. No evidence of pt. request or MD order for telehealth visits. Patient 2: MSW visit 4/5/24 conducted via telephone. No evidence of pt. request or MD order for telehealth visits. Patient 3: MSW visit 4/11/24 conducted via telephone. No evidence of pt. request or MD order for telehealth visits. Patient 8: MSW visit 4/07/24 conducted via telephone. No evidence of pt. request or MD order for telehealth visits.